Portfolio Grader currently ranks Bristol-Myers Squibb Co (NYSE:BMY) a Hold. With exclusive fundamental and quantitative analytical tools developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. The shares have been upgraded from a Sell to a Hold in the last week.
BMY ranks in the top decile in its industry group, Pharmaceuticals, and in the top 10% of its sector group, Health Care, with a market value of $98.2 billion.
The Health Care sector is ranked number 8 among the 12 sectors in the Portfolio Grader universe putting it in the third quartile of all the GICS sectors. The Pharmaceuticals industry group is ranked 56 among the 69 industry groups within the GICS sectors, placing it well below-average in terms of the Navellier scoring system.
Bristol-Myers Squibb Co has earned above-average scores in 3 of the 8 fundamental areas analyzed by Portfolio Grader and average or below-average scores in 5 of the areas evaluated in the ranking of company stocks.
BMY's operational scores are below the industry norms for sales growth, operating margin, and earnings growth. Scores for visibility of earnings are mixed, with a ranking for earnings surprises and earnings momentum that are worse than average, while the score for earnings revisions is better than average. BMY's grades for cash flow and return on equity are noticeably better than its industry group average. These fundamental scores give Bristol-Myers Squibb Co a position in the top half of the industry group.
Portfolio Grader uses the Navellier Proprietary Quantitative Score to measure BMY's shares from the viewpoint of risk/reward. This exclusive scoring approach weighs the relative value of BMY's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Considering this risk/reward calculation, the company currently scores as average in its industry group compared to its peers.
Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.
Commentary provided by UpTick Data Technologies.
